CIK 0000749647 · Non-accelerated filer<br>Smaller reporting company
Imunon, Inc.
Sign in to watch- Ticker
- IMNN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521256615
- Phone
- (609) 896-9100
- Business address
- 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NJ, 08648
- Former names
- CELSION CORP, Celsion CORP, CHEUNG LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,942
- in 2 filings
Net −$7,942. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | Braun Donald P Director | Grant or award | +11,746 | $0.85 | $10K | 33,643 |
| 2026-11-06 | Dentzer James E Director | Grant or award | +13,166 | $0.85 | $11K | 34,197 |
| 2026-11-06 | Pellizzari Christine A Director | Grant or award | +13,166 | $0.85 | $11K | 28,665 |
| 2026-11-06 | Fritz Frederick J. Director | Grant or award | +13.17 | $0.85 | $11 | 28,242 |
| 2026-11-06 | Faller Douglas Vincent Chief Medical Officer | Grant or award | +1,596 | $0.85 | $1K | 76,356 |
| 2026-11-06 | Lindborg Stacy President and CEO | Grant or award | +3,804 | $0.85 | $3K | 122,581 |
| 2026-11-06 | Tardugno Michael H Executive Chairman of Board | Grant or award | +9,969 | $0.85 | $8K | 128,511 |
| 2026-10-23 | Tardugno Michael H Executive Chairman of Board | Grant or award | +6,821 | $1.24 | $8K | 118,542 |
| 2026-10-23 | Lindborg Stacy President and CEO | Grant or award | +2,603 | $1.24 | $3K | 118,777 |
| 2026-10-23 | Faller Douglas Vincent Chief Medical Officer | Grant or award | +26,741 | $1.24 | $33K | 74,760 |
| 2026-10-23 | Faller Douglas Vincent Chief Medical Officer | Grant or award | +1,092 | $1.24 | $1K | 48,019 |
| 2026-10-09 | Tardugno Michael H Executive Chairman of Board | Grant or award | +7,800 | $1.08 | $8K | 111,721 |
| 2026-10-09 | Lindborg Stacy President and CEO | Grant or award | +2,977 | $1.08 | $3K | 116,174 |
| 2026-10-09 | Faller Douglas Vincent Chief Medical Officer | Grant or award | +1,249 | $1.08 | $1K | 46,927 |
| 2026-09-25 | Tardugno Michael H Executive Chairman of Board | Grant or award | +7,169 | $1.41 | $10K | 103,921 |
| 2026-09-25 | Lindborg Stacy President and CEO | Grant or award | +6,697 | $1.41 | $9K | 113,197 |
| 2026-09-25 | Faller Douglas Vincent Chief Medical Officer | Grant or award | +4,390 | $1.41 | $6K | 45,678 |
| 2026-09-11 | Tardugno Michael H Executive Chairman of Board | Grant or award | +5,824 | $1.47 | $9K | 95,699 |
| 2026-09-11 | Lindborg Stacy President and CEO | Grant or award | +5,504 | $1.47 | $8K | 105,580 |
| 2026-09-11 | Faller Douglas Vincent Chief Medical Officer | Grant or award | +4,211 | $1.47 | $6K | 41,288 |
Page 1 of 6 · 119 trades